WHO ICTRP trial
A Bioequivalence study of a randomized, open-label, single dose, fully replicate…
TCTR20200120004 · Thai Clinical Trials Registry (TCTR) · Not Recruiting
Key facts
| Trial ID | TCTR20200120004 |
|---|---|
| Public title | A Bioequivalence study of a randomized, open-label, single dose, fully replicate crossover design with four-period, two-treatment and two-sequence of Atorvastatin 80 mg tablets relative to Lipitor(R) 80 mg tablets in healthy Thai volunteers under fasting condition |
| Scientific title | A Bioequivalence study of a randomized, open-label, single dose, fully replicate crossover design with four-period, two-treatment and two-sequence of Atorvastatin 80 mg tablets relative to Lipitor(R) 80 mg tablets in healthy Thai volunteers under fa |
| Primary sponsor | Bio-innova and Synchron.Co.,Ltd |
| Registry | Thai Clinical Trials Registry (TCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 0 |
| Countries | Thailand |
| Conditions | Bioequivalence study Bioequivalence study Atorvastatin;Bioequivalence study Atorvastatin |
| Interventions | A randomized, open-labeled, single-dose, fully replicate crossover design with four-period, two-treatment and two-sequence under fasting conditions and at least 7 days washout period between the doses.,A randomized, open-labeled… |
| Registration date | Jan 20, 2020 |
| Target size | 30 |
| Registry page | thaiclinicaltrials.org |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: